Sickle Cell
Protocol:GBT440-034
Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: An Open Label Extension Study GBT440 administered Orally to Patients with Sickle Cell Disease Who Have Participate in GBR440 Clinical Trials.
Principal I investigator: Alan Ikeda, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03573882
